Helicobacter pylori. Disease of stomach and duodenum, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Add curcumin 500 mg tablet daily to Helicobacter pylori eradication regimen for 2 weeks. Intervention 2: Control group: Adding curcumin placebo, as a daily tablet
Sponsors
Sanandaj University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with dyspepsia, nausea, vomiting and epigastric inflammation, and evidence of Helicobacter infection after endoscopy, in which positive urease test and then Hpylori IgG test were positive.
Exclusion criteria
Exclusion criteria: HIV infection, known cancers, antibiotic use in a recent month, acute gastrointestinal bleeding, proton pump inhibitor intake in a recent month, pregnancy or breastfeeding, allergy to turmeric and gingerbread
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori eradication. Timepoint: 1 week after the end of medication. Method of measurement: UBT Test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects of the treatment regimen. Timepoint: 1 week after the end of medication. Method of measurement: Asking the patient. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Farshad Sheikhesmaeili
Sanandaj University of Medical Sciences
Outcome results
None listed